Intravitreal aflibercept for the treatment of patients with diabetic macular edema in routine clinical practice in Latin America: the AQUILA study

被引:0
|
作者
Francisco J. Rodríguez
Lihteh Wu
Arnaldo F. Bordon
Martin Charles
JinKyung Lee
Tobias Machewitz
Margarete Mueller
Gabriela del Carmen Gay
Jans Fromow-Guerra
机构
[1] Fundación Oftalmológíca Nacional,Asociados de Macula
[2] Universidad del Rosario School of Medicine,undefined
[3] Vitreo y Retina de Costa Rica,undefined
[4] Hospital Oftalmológico de Sorocaba,undefined
[5] Centro Oftalmológico Dr Charles,undefined
[6] Bayer AG,undefined
[7] Bayer SA,undefined
[8] Macula Retina Consultores,undefined
关键词
Macula; Vision; Clinical trial;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Effectiveness of intravitreal aflibercept injections for anti-VEGF treatment-naive patients with diabetic macular edema in UK routine clinical practice (DRAKO): 12-month results
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon P.
    Kotagiri, Ajay
    Talks, James S.
    Scanlon, Peter Henry
    Saddiq, Moneeb
    Napier, Jackie
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [32] Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes
    Masahiko Sugimoto
    Chiharu Handa
    Kazufumi Hirano
    Toshiyuki Sunaya
    Mineo Kondo
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 283 - 287
  • [33] Treatment Outcomes of Intravitreal Aflibercept for Uveitic Macular Edema
    Oyeniran, Enny
    Bhandari, Sanjeeb
    Amir, Ali
    Soifer, Matias
    Bellur, Sunil
    Vitale, Susan
    Sen, H. Nida
    Kodati, Shilpa
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2024,
  • [34] Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
    Hein, Martin
    Vukmirovic, Aleksandar
    Constable, Ian J.
    Raja, Vignesh
    Athwal, Arman
    Freund, K. Bailey
    Balaratnasingam, Chandrakumar
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [35] Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
    Martin Hein
    Aleksandar Vukmirovic
    Ian J. Constable
    Vignesh Raja
    Arman Athwal
    K. Bailey Freund
    Chandrakumar Balaratnasingam
    [J]. Scientific Reports, 13
  • [36] The clinical utility of aflibercept for diabetic macular edema
    Stewart, Michael W.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2015, 8 : 473 - 482
  • [37] Cost-effectiveness analysis of intravitreal aflibercept in the treatment of diabetic macular edema in China
    Ming, Jian
    Zhang, Yabing
    Xu, Xun
    Zhao, Mingwei
    Wang, Yusheng
    Chen, Youxin
    Zhang, Feng
    Wang, Jiawei
    Liu, Jun
    Zhao, Xinran
    Han, Rong
    Hu, Shanlian
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (03) : 161 - 175
  • [38] Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema Extrapolation of Data to Clinical Practice
    Heier, Jeffrey S.
    Bressler, Neil M.
    Avery, Robert L.
    Bakri, Sophie J.
    Boyer, David S.
    Brown, David M.
    Dugel, Pravin U.
    Freund, K. Bailey
    Glassman, Adam R.
    Kim, Judy E.
    Martin, Daniel F.
    Pollack, John S.
    Regillo, Carl D.
    Rosenfeld, Philip J.
    Schachat, Andrew P.
    Wells, John A., III
    [J]. JAMA OPHTHALMOLOGY, 2016, 134 (01) : 95 - 99
  • [39] Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept
    Blindbaek, Soren Leer
    Peto, Tunde
    Grauslund, Jakob
    [J]. OPHTHALMIC RESEARCH, 2020, 63 (02) : 106 - 113
  • [40] DIABETIC MACULAR EDEMA IN NAIVE PATIENTS TREATED BY INTRAVITREAL OZURDEX IN CLINICAL PRACTICE: The "DIMENTION" Study.
    Raphaelle, Despreaux
    Touhami, Sara
    Virevialle, Clemence
    Adam, Raphael
    Nordmann, Jean Philippe
    Akesbi, Jad
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)